2012
DOI: 10.1016/j.alcohol.2012.05.003
|View full text |Cite
|
Sign up to set email alerts
|

Disturbances in behavior and cortical enkephalin gene expression during the anticipation of ethanol in rats characterized as high drinkers

Abstract: The process of ethanol anticipation is a particularly important phenomenon that can determine subsequent drug-taking behavior. Recent studies suggest that systems within the medial prefrontal cortex (mPFC), during anticipation, may contribute to the goal-directed seeking of ethanol. The current investigation examined the possibility that the opioid peptide enkephalin (ENK), known to mediate some of the reinforcing properties of ethanol, may function in the mPFC during the anticipation of ethanol access. Using … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
11
0

Year Published

2015
2015
2019
2019

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(12 citation statements)
references
References 68 publications
0
11
0
Order By: Relevance
“…Several studies have suggested that these deficits arise from supernormal opioid transmission (Blasio et al 2014; Gorelick et al 2008; Love et al 2009; Mitchell et al 2012; Morganstern et al 2012; Selleck et al 2015; Zubieta et al 1996), and these studies are supported by clinical findings that opioid antagonists have at least some degree of efficacy across several disorders characterized by loss of control over goal-seeking behavior (Cambridge et al 2013; Kim et al 2001; Mitchell et al 2007; Volpicelli et al 1992). However, there is variability in the reports of opiate antagonist clinical efficacy (McElroy et al 2013; Ziauddeen et al 2013), suggesting that further studies are needed to more thoroughly delineate opioid actions within the brain and how normal brain function is influenced by opioid antagonists.…”
Section: Discussionmentioning
confidence: 91%
“…Several studies have suggested that these deficits arise from supernormal opioid transmission (Blasio et al 2014; Gorelick et al 2008; Love et al 2009; Mitchell et al 2012; Morganstern et al 2012; Selleck et al 2015; Zubieta et al 1996), and these studies are supported by clinical findings that opioid antagonists have at least some degree of efficacy across several disorders characterized by loss of control over goal-seeking behavior (Cambridge et al 2013; Kim et al 2001; Mitchell et al 2007; Volpicelli et al 1992). However, there is variability in the reports of opiate antagonist clinical efficacy (McElroy et al 2013; Ziauddeen et al 2013), suggesting that further studies are needed to more thoroughly delineate opioid actions within the brain and how normal brain function is influenced by opioid antagonists.…”
Section: Discussionmentioning
confidence: 91%
“…μORs are upregulated in the PFC (along with the Acb and amygdala) in individuals with trait impulsivity, and these individuals display exaggerated stressor-induced PFC opioid release (Love et al, 2009). In animal studies, PFClocalized μ-opioid peptides are elevated after exposure to 'binge-like' palatable feeding or cocaine self-administration schedules, and in rats predisposed to excessive ethanol intake (Blasio et al, 2013;Morganstern et al, 2012). Finally, intra-PFC naloxone infusion reduced food-reinforced PR responding in rats that had experienced a 'binge'-inducing schedule of sugar access (Blasio et al, 2013).…”
Section: Discussionmentioning
confidence: 99%
“…For example, high alcohol drinking rats exhibit a greater level of mu-opioid receptor (MOR)-associated and enkephalin mRNA, compared to low alcohol drinking rats (Morganstern et al, 2012). For a review of neurobiological differences in the opioid system between selectively bred high and low alcohol-consuming rats see Bell et al (2012).…”
Section: Some Neurochemical Neuropharmacological As Well As Neurmentioning
confidence: 99%